Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Open in API
Filings indexed 1,550 across all filing types
Latest filing 2020-02-13 Regulatory Filings
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Bodal Chemicals Limited has informed the Exchange regarding News Paper Publications for Result
Regulatory Filings
2020-02-13 English
Bodal Chemicals Ltd has informed BSE that the meeting of the Board of Directors was held on February 12, 2020, inter alia, has considered and declared interim dividend @ Rs.0.80 per equity ....
Regulatory Filings
2020-02-12 English
Bodal Chemicals Ltd herewith inform Exchange about Grant of Employee Stock Options.
Regulatory Filings
2020-02-12 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document text provides details about stock options granted under an Employee Stock Option Plan (ESOP) for Bodal Chemicals Limited. It includes specifics such as the number of options, exercise price, vesting schedule, and regulatory compliance with the Securities and Exchange Board of India (SEBI) regulations. This type of information is typically related to share-based compensation disclosures rather than a full financial report or announcement. It does not contain financial statements or earnings data, nor is it an announcement of voting results or management changes. The content aligns best with disclosures about share-based payments or capital changes related to stock options. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length is short and focused on stock options, supporting this classification with high confidence.
2020-02-12 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is titled 'Statement of Deviation/ Variation in utilisation of Funds raised through Preferential Allotment' and references Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It reports on the use of funds raised through equity warrants via preferential allotment, specifically stating there is no deviation or variation in the use of funds. The document is addressed to stock exchanges and is a compliance report related to fund utilization. It does not contain financial statements or detailed financial performance data but is a regulatory compliance filing reporting on fund usage deviation status. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement and compliance document rather than a financial report or capital update itself.
2020-02-12 English
Acquisition
Regulatory Filings
2020-02-12 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.